Lurasidone as a potential therapy for bipolar disorder
Young Sup Woo, Hee Ryung Wang, Won-Myong Bahk Department of Psychiatry, Yeouido St Mary's Hospital, The Catholic University of Korea, Seoul, Korea Abstract: Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute t...
Guardado en:
Autores principales: | Woo YS, Wang HR, Bahk WM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc7a54e3b15f4ed8993d5ea38d81b303 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin R, et al.
Publicado: (2015) -
Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang HR, et al.
Publicado: (2015) -
Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong JH, et al.
Publicado: (2015) -
Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo YS, et al.
Publicado: (2015) -
Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
por: Bae SO, et al.
Publicado: (2013)